256 related articles for article (PubMed ID: 8824468)
21. Hyperacute lung rejection in the pig-to-human model. 2. Synergy between soluble and membrane complement inhibition.
Azimzadeh A; Zorn GL; Blair KS; Zhang JP; Pfeiffer S; Harrison RA; Cozzi E; White DJ; Pierson RN
Xenotransplantation; 2003 Mar; 10(2):120-31. PubMed ID: 12588645
[TBL] [Abstract][Full Text] [Related]
22. Orthotopic heart transplantation in a transgenic pig-to-primate model.
Schmoeckel M; Bhatti FN; Zaidi A; Cozzi E; Waterworth PD; Tolan MJ; Pino-Chavez G; Goddard M; Warner RG; Langford GA; Dunning JJ; Wallwork J; White DJ
Transplantation; 1998 Jun; 65(12):1570-7. PubMed ID: 9665072
[TBL] [Abstract][Full Text] [Related]
23. Protection of xenogeneic cardiac endothelium from human complement by expression of CD59 or DAF in transgenic mice.
Byrne GW; McCurry KR; Kagan D; Quinn C; Martin MJ; Platt JL; Logan JS
Transplantation; 1995 Nov; 60(10):1149-56. PubMed ID: 7482724
[TBL] [Abstract][Full Text] [Related]
24. [Xenotransplantation of hDAF-transgenic swine hearts].
Schmoeckel M; Cozzi E; Chavez G; Dunning JJ; Wallwork J; White DJ
Zentralbl Chir; 1999; 124(7):604-8. PubMed ID: 10474873
[TBL] [Abstract][Full Text] [Related]
25. Influence of ischemic time on hyperacute xenograft rejection of pig hearts in a working heart perfusion model with human blood.
Brenner P; Hinz M; Huber H; Schmoeckel M; Reichenspurner H; Meiser B; Hammer C; Reichart B
Transpl Int; 2000; 13 Suppl 1():S494-503. PubMed ID: 11112061
[TBL] [Abstract][Full Text] [Related]
26. Combination of decay-accelerating factor expression and alpha1,3-galactosyltransferase knockout affords added protection from human complement-mediated injury.
van Denderen BJ; Salvaris E; Romanella M; Aminian A; Katerelos M; Tange MJ; Pearse MJ; d'Apice AJ
Transplantation; 1997 Sep; 64(6):882-8. PubMed ID: 9326415
[TBL] [Abstract][Full Text] [Related]
27. Expression of human decay accelerating factor (hDAF) in transgenic pigs regulates complement activation during ex vivo liver perfusion--immunopathological findings.
Pascher A; Poehlein C; Storck M; Abendroth D; Mueller-Hoecker J; Koenig W; Young VK; White DJ; Hammer C
Transpl Int; 1996; 9 Suppl 1():S385-7. PubMed ID: 8959869
[TBL] [Abstract][Full Text] [Related]
28. Hearts from transgenic pigs constructed with CD59/DAF genomic clones demonstrate improved survival in primates.
Chen RH; Naficy S; Logan JS; Diamond LE; Adams DH
Xenotransplantation; 1999 Aug; 6(3):194-200. PubMed ID: 10503786
[TBL] [Abstract][Full Text] [Related]
29. Loss of ecto-5'nucleotidase from porcine endothelial cells after exposure to human blood: Implications for xenotransplantation.
Khalpey Z; Yuen AH; Kalsi KK; Kochan Z; Karbowska J; Slominska EM; Forni M; Macherini M; Bacci ML; Batten P; Lavitrano M; Yacoub MH; Smolenski RT
Biochim Biophys Acta; 2005 Jun; 1741(1-2):191-8. PubMed ID: 15955461
[TBL] [Abstract][Full Text] [Related]
30. The influence of antibody and complement removal with a Ig-Therasorb column in a xenogeneic working heart model.
Brenner P; Hinz M; Huber H; Schmoeckel M; Reichenspurner H; Meiser B; Hammer C; Reichart B
Eur J Cardiothorac Surg; 1999 May; 15(5):672-9. PubMed ID: 10386416
[TBL] [Abstract][Full Text] [Related]
31. Effect of complement fragment 1 esterase inhibition on survival of human decay-accelerating factor pig lungs perfused with human blood.
Schröder C; Pfeiffer S; Wu G; Zorn GL; Ding L; Allen C; Harrison RA; White DJ; Azimzadeh AM; Pierson RN
J Heart Lung Transplant; 2003 Dec; 22(12):1365-75. PubMed ID: 14672751
[TBL] [Abstract][Full Text] [Related]
32. Prevention of hyperacute xenograft rejection in orthotopic xenotransplantation of pig hearts into baboons using immunoadsorption of antibodies and complement factors.
Brenner P; Reichenspurner H; Schmoeckel M; Wimmer C; Rucker A; Eder V; Meiser B; Hinz M; Felbinger T; Hammer C; Reichart B
Transpl Int; 2000; 13 Suppl 1():S508-17. PubMed ID: 11112063
[TBL] [Abstract][Full Text] [Related]
33. [Xenotransplantation].
White DJ; Calne RY
Chirurg; 1996 Apr; 67(4):324-30. PubMed ID: 8646917
[TBL] [Abstract][Full Text] [Related]
34. Human DAF on pig cells protects against human and non-human primate sera cytotoxicity mediated by exogenous or endogenous complement, as determined by flow cytometry.
Díaz-Román TM; Mañez R; López-Pelaez E; Centeno A; Moscoso I; Pértegaz S; Doménech N
Transpl Immunol; 2006 Aug; 16(2):125-30. PubMed ID: 16860716
[TBL] [Abstract][Full Text] [Related]
35. Characterization of pigs transgenic for human decay-accelerating factor.
Cozzi E; Tucker AW; Langford GA; Pino-Chavez G; Wright L; O'Connell MJ; Young VJ; Lancaster R; McLaughlin M; Hunt K; Bordin MC; White DJ
Transplantation; 1997 Nov; 64(10):1383-92. PubMed ID: 9392299
[TBL] [Abstract][Full Text] [Related]
36. Fluorescent microspheres reveal different regional blood flow in hyperacutely rejected nontransgenic and hDAF pig hearts.
Brandl U; Erhardt M; Jöckle H; Michel S; Thein E; Bittmann I; Brenner P; Burdorf L; Hammer C; Schmoeckel M; Reichart B
Transplant Proc; 2006 Apr; 38(3):733-4. PubMed ID: 16647457
[TBL] [Abstract][Full Text] [Related]
37. Life-supporting pig-to-baboon heart xenotransplantation.
Waterworth PD; Dunning J; Tolan M; Cozzi E; Langford G; Chavez G; White D; Wallwork J
J Heart Lung Transplant; 1998 Dec; 17(12):1201-7. PubMed ID: 9883761
[TBL] [Abstract][Full Text] [Related]
38. The pig analogue of CD59 protects transgenic mouse hearts from injury by human complement.
Fisicaro N; Aminian A; Hinchliffe SJ; Morgan BP; Pearse MJ; D'Apice AJ; Cowan PJ
Transplantation; 2000 Sep; 70(6):963-8. PubMed ID: 11014650
[TBL] [Abstract][Full Text] [Related]
39. Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage.
Byrne GW; McCurry KR; Martin MJ; McClellan SM; Platt JL; Logan JS
Transplantation; 1997 Jan; 63(1):149-55. PubMed ID: 9000677
[TBL] [Abstract][Full Text] [Related]
40. The xenoantibody response and immunoglobulin gene expression profile of cynomolgus monkeys transplanted with hDAF-transgenic porcine hearts.
Zahorsky-Reeves JL; Kearns-Jonker MK; Lam TT; Jackson JR; Morris RE; Starnes VA; Cramer DV
Xenotransplantation; 2007 Mar; 14(2):135-44. PubMed ID: 17381688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
